Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-23

Clinical Trial Update: MRI Background Parenchymal Enhancement as a Risk Factor for Breast Cancer: The IMAGINg and Epidemiology (IMAGINE) Study

View source ↗

Summary

The IMAGINE study is exploring whether MRI background parenchymal enhancement is a risk factor for breast cancer, and the trial is currently active but not recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Breast Cancer | Status: ACTIVE_NOT_RECRUITING